Renhe Pharmacy’s controlling shareholder plans minor share reduction

Renhe (Group) Development Co., Ltd., the controlling shareholder of Renhe Pharmacy, has announced its intention to reduce its holdings in the company. As of the disclosure date, Renhe Group holds 325,299,386 unrestricted shares, representing 23.2367% of the company’s total share capital.

The planned reduction involves selling up to 3,000,000 shares, which constitutes no more than 0.2143% of Renhe Pharmacy’s total share capital. The sales will occur within three months following 15 trading days from the announcement date, using either centralized competitive bidding or block trading methods. This move is attributed to Renhe Group’s own development needs.

Renhe Group has confirmed that all prior commitments, including those made during the equity split reform, have been fulfilled. The company assures investors that this share reduction will not alter the company’s control or negatively impact its operational stability and governance structure.